Panelists:
Stefano Nava, MD,
Semra Bilaceroglu, MD,
Mangala Narasimhan, DO, FCCP

Learning Objectives:
• Share with the panel for their awareness and comment, if desired.
• Appraise investigational and repurposed therapeutic agents in development for treating COVID-19 infection.
• Recognize differences in epidemiology related to outcomes across three international regions.
• Identify best methods to protect against COVID-19 transmission.

Gerard A. Silvestri, MD, FCCP

Learning Objectives
• Define the epidemiology of this disorder.
• Review the diagnostic approach to distinguishing benign from malignant disease.
• Better understand when to use lung biopsy, PET scan, or surgery for the management of lung nodules.
• Introduce how blood biomarkers will potentially be used in this space.

Sandhya Khurana, MD, FCCP

Learning Objectives
• Discuss recent advances in the understanding of pathobiology of asthma.
• List available asthma biomarkers and their role in pheno-endotyping.
• Review targeted treatment options in severe asthma.

Sergio Harari, MD

Learning Objectives
• Provide a change of perspective for COVID-19 infection and ILD.
• Review pulmonary fibrosis after COVID-19 disease.
• Describe common approaches to COVID-19 disease and ILD.

Neil S. Freedman, MD, FCCP

Session Description
Obesity hypoventilation syndrome (OHS) is a relatively common cause of chronic hypercapnic respiratory failure and can occur with or without obstructive sleep apnea, yet the optimal approach to treatment is not well defined. This will be a case-based interactive session that will review current diagnostic criteria, recent literature and guidelines, and various management strategies. During this session, the faculty and attendees will also review the role of CPAP and more advanced nocturnal ventilatory modalities on outcomes in patients with OHS.
Learning Objectives
• Define obesity hypoventilation syndrome (OHS) and diagnostic approaches.
• Understand the most recent literature and guidelines related to the management of OHS.
• List different management strategies, including the use of various nocturnal ventilatory modes, that may improve outcomes in this patient population.

Steven Q. Simpson, MD, FCCP

Learning Objectives
• Discuss the longer-term implications of a sepsis hospitalization.
• Apply SV-based volume resuscitation for septic patients.
• Treat sepsis early in its course, and aggressively.

Bartolome R. Celli, MD, FCCP

Learning Objectives
• Describe the COPD landscape in the USA and the world.
• Provide a practical approach to initiate and modify pharmacotherapy in patients with COPD.
• Review the tools available for patients receiving maximal therapy who remain functionally impaired.

Lisa K. Moores, MD, FCCP
Learning Objectives
• Review the pathophysiology of VTE and how this manifests in patients with COVID-19.
• Discuss optimal methods of prophylaxis.
• Apply recently published guidelines to the management of patients with COVID-19.

Otis Rickman, DO, FCCP
Learning Objectives
• Understand how to safely perform bronchoscopy in patients with COVID-19.
• List aerosol-generating pulmonary procedures.
• Minimize COVID-19 infection risk when performing percutaneous tracheostomy.